CY1120608T1 - Φαρμακευτικως δραστικες ενωσεις - Google Patents
Φαρμακευτικως δραστικες ενωσειςInfo
- Publication number
- CY1120608T1 CY1120608T1 CY181100275T CY181100275T CY1120608T1 CY 1120608 T1 CY1120608 T1 CY 1120608T1 CY 181100275 T CY181100275 T CY 181100275T CY 181100275 T CY181100275 T CY 181100275T CY 1120608 T1 CY1120608 T1 CY 1120608T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compounds
- active compounds
- pharmaceutical active
- formula
- relates
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 abstract 2
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000005441 aurora Substances 0.000 abstract 1
- 239000003719 aurora kinase inhibitor Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1211021.9A GB201211021D0 (en) | 2012-06-21 | 2012-06-21 | Pharmaceutically active compounds |
| PCT/GB2013/051633 WO2013190319A1 (en) | 2012-06-21 | 2013-06-21 | Pharmaceutically active compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1120608T1 true CY1120608T1 (el) | 2019-12-11 |
Family
ID=46641296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY181100275T CY1120608T1 (el) | 2012-06-21 | 2018-03-06 | Φαρμακευτικως δραστικες ενωσεις |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9447092B2 (enExample) |
| EP (1) | EP2864328B8 (enExample) |
| JP (1) | JP6159397B2 (enExample) |
| CN (1) | CN104470922B (enExample) |
| AU (1) | AU2013279040B2 (enExample) |
| BR (1) | BR112014032142B1 (enExample) |
| CA (1) | CA2876357C (enExample) |
| CY (1) | CY1120608T1 (enExample) |
| DK (1) | DK2864328T3 (enExample) |
| ES (1) | ES2660159T3 (enExample) |
| GB (1) | GB201211021D0 (enExample) |
| HR (1) | HRP20180386T1 (enExample) |
| HU (1) | HUE036048T2 (enExample) |
| IN (1) | IN2015MN00045A (enExample) |
| LT (1) | LT2864328T (enExample) |
| NO (1) | NO2864328T3 (enExample) |
| PL (1) | PL2864328T3 (enExample) |
| PT (1) | PT2864328T (enExample) |
| RS (1) | RS56996B1 (enExample) |
| RU (1) | RU2654942C2 (enExample) |
| SI (1) | SI2864328T1 (enExample) |
| SM (1) | SMT201800128T1 (enExample) |
| WO (1) | WO2013190319A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201522532D0 (en) * | 2015-12-21 | 2016-02-03 | Cancer Rec Tech Ltd | Novel pyrrolo[3,2-c]pyridine-6-amino derivatives |
| WO2017146253A1 (ja) | 2016-02-26 | 2017-08-31 | 公益財団法人がん研究会 | Ｈｐ１の機能に着目した抗癌剤のスクリーニング方法及び評価系 |
| GB2596038B (en) * | 2020-03-04 | 2022-12-14 | Ellipses Pharma Ltd | Salts and polymorphic forms of (6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-B]pyridine) |
| GB2592622B (en) * | 2020-03-04 | 2022-08-03 | Ellipses Pharma Ltd | Formulations of a dual aurora kinase/FLT3 inhibitor |
| WO2026017996A1 (en) | 2024-07-16 | 2026-01-22 | Ellipses Pharma Ltd | Combinations of cct241736 and venetoclax, or of cct241736, venetoclax and azacitidine for use in the treatment of cancer |
| WO2026020051A1 (en) * | 2024-07-19 | 2026-01-22 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading aurora kinase via ubiquitin proteosome pathway |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| CA2242425C (en) | 1996-02-13 | 2006-07-18 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| BR0111230A (pt) | 2000-05-31 | 2003-06-10 | Astrazeneca Ab | Composto, e, uso e processo para a preparação do mesmo |
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| EE200300015A (et) | 2000-07-07 | 2004-10-15 | Angiogene Pharmaceuticals Limited | Kolhinooli derivaadid kui angiogeneesi inhibiitorid |
| KR20030014425A (ko) | 2000-07-07 | 2003-02-17 | 앤지오젠 파마슈티칼스 리미티드 | 혈관 손상제인 콜치놀 유도체 |
| JP2004536113A (ja) * | 2001-07-03 | 2004-12-02 | カイロン コーポレイション | チロシンキナーゼおよびセリン／スレオニンキナーゼのインヒビターとしてのインダゾールベンズイミダゾール化合物 |
| TWI372050B (en) * | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
| CN102127078A (zh) * | 2005-07-14 | 2011-07-20 | 安斯泰来制药株式会社 | Janus激酶3的杂环类抑制剂 |
| EP1963315B1 (en) * | 2005-12-22 | 2014-10-08 | Cancer Research Technology Limited | Enzyme inhibitors |
| CN101616920A (zh) * | 2007-01-30 | 2009-12-30 | 比奥根艾迪克Ma公司 | 1-H-吡唑并(3,4b)嘧啶衍生物及其作为有丝分裂激酶调节剂的用途 |
| WO2009001021A1 (en) | 2007-06-26 | 2008-12-31 | Chroma Therapeutics Ltd. | Imidazopyridine derivatives useful as enzyme inhibitors for the treatment of cell proliferative and autoimmune diseases |
| CA2728559A1 (en) * | 2008-07-03 | 2010-01-07 | Exelixis Inc. | Cdk modulators |
| EP2616469B1 (en) * | 2010-09-14 | 2016-10-26 | Exelixis, Inc. | 9h-purine compounds as pi3k-delta inhibitors and methods for their manufacture |
-
2012
- 2012-06-21 GB GBGB1211021.9A patent/GB201211021D0/en not_active Ceased
-
2013
- 2013-06-21 LT LTEP13731470.4T patent/LT2864328T/lt unknown
- 2013-06-21 DK DK13731470.4T patent/DK2864328T3/en active
- 2013-06-21 EP EP13731470.4A patent/EP2864328B8/en active Active
- 2013-06-21 IN IN45MUN2015 patent/IN2015MN00045A/en unknown
- 2013-06-21 BR BR112014032142-6A patent/BR112014032142B1/pt active IP Right Grant
- 2013-06-21 AU AU2013279040A patent/AU2013279040B2/en active Active
- 2013-06-21 CN CN201380032901.2A patent/CN104470922B/zh active Active
- 2013-06-21 RS RS20180267A patent/RS56996B1/sr unknown
- 2013-06-21 SM SM20180128T patent/SMT201800128T1/it unknown
- 2013-06-21 HU HUE13731470A patent/HUE036048T2/hu unknown
- 2013-06-21 RU RU2015101702A patent/RU2654942C2/ru active
- 2013-06-21 SI SI201330965T patent/SI2864328T1/en unknown
- 2013-06-21 ES ES13731470.4T patent/ES2660159T3/es active Active
- 2013-06-21 JP JP2015517858A patent/JP6159397B2/ja active Active
- 2013-06-21 PT PT137314704T patent/PT2864328T/pt unknown
- 2013-06-21 CA CA2876357A patent/CA2876357C/en active Active
- 2013-06-21 NO NO13731470A patent/NO2864328T3/no unknown
- 2013-06-21 PL PL13731470T patent/PL2864328T3/pl unknown
- 2013-06-21 HR HRP20180386TT patent/HRP20180386T1/hr unknown
- 2013-06-21 US US14/409,042 patent/US9447092B2/en active Active
- 2013-06-21 WO PCT/GB2013/051633 patent/WO2013190319A1/en not_active Ceased
-
2018
- 2018-03-06 CY CY181100275T patent/CY1120608T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO2864328T3 (enExample) | 2018-05-05 |
| JP6159397B2 (ja) | 2017-07-05 |
| JP2015520222A (ja) | 2015-07-16 |
| GB201211021D0 (en) | 2012-08-01 |
| WO2013190319A1 (en) | 2013-12-27 |
| ES2660159T3 (es) | 2018-03-21 |
| US9447092B2 (en) | 2016-09-20 |
| HUE036048T2 (hu) | 2018-06-28 |
| AU2013279040A1 (en) | 2015-01-29 |
| BR112014032142B1 (pt) | 2022-03-03 |
| LT2864328T (lt) | 2018-04-10 |
| BR112014032142A2 (pt) | 2017-06-27 |
| HRP20180386T1 (hr) | 2018-04-20 |
| RS56996B1 (sr) | 2018-05-31 |
| AU2013279040B2 (en) | 2017-11-16 |
| RU2015101702A (ru) | 2016-08-10 |
| CA2876357C (en) | 2020-07-14 |
| PT2864328T (pt) | 2018-03-12 |
| IN2015MN00045A (enExample) | 2015-10-16 |
| EP2864328B8 (en) | 2018-01-24 |
| CN104470922A (zh) | 2015-03-25 |
| PL2864328T3 (pl) | 2018-06-29 |
| SMT201800128T1 (it) | 2018-05-02 |
| CN104470922B (zh) | 2016-08-24 |
| CA2876357A1 (en) | 2013-12-27 |
| RU2654942C2 (ru) | 2018-05-25 |
| EP2864328B1 (en) | 2017-12-06 |
| DK2864328T3 (en) | 2018-03-12 |
| EP2864328A1 (en) | 2015-04-29 |
| US20150266868A1 (en) | 2015-09-24 |
| SI2864328T1 (en) | 2018-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123756T1 (el) | Παραγωγα διπυραζολιου ως αναστολεις jak | |
| CY1123616T1 (el) | 7-βενζυλ-4-(4-(τριφθορομεθυλ)βενζυλ)-1,2,6,7,8,9-εξαϋδροϊμιδαζο[1,2-α]πυριδο[3,4-ε]πυριμιδιν-5(4η)-ονη, και αλατα αυτης και χρηση αυτων στη θεραπεια | |
| CY1120334T1 (el) | Υποκατεστημενης 3-αλλογονοαλυλαμινης αναστολεις ssao και χρησεις αυτων | |
| CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
| CY1122601T1 (el) | Αναστολεις gsk3 και μεθοδοι χρησης αυτων | |
| CY1120104T1 (el) | Αναστολεις της syk | |
| CY1119939T1 (el) | Παραγωγα 2,3-διϋδρο-βενζο[1,4]οξαζιν και σχετικες ενωσεις οπως αναστολεις φωσφοϊνοσιτινης-3 κινασης (ρι3κ) για τη θεραπεια παραδειγματος χαρην της ρευματοειδους αρθριτιδας | |
| CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
| CY1126109T1 (el) | Αναστολεις toy trpc6 | |
| EA201591753A1 (ru) | 3-пиримидин-4-илоксазолидин-2-оны в качестве ингибиторов мутантного idh | |
| CY1118340T1 (el) | Αναστολεις κινασης | |
| EA201591727A1 (ru) | Соединения биариламида в качестве ингибиторов киназы | |
| EA201790599A1 (ru) | Соединения и композиции в качестве ингибиторов киназ | |
| EA201691058A1 (ru) | Производные пирролопирролона и их применение для лечения заболеваний | |
| EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
| CY1117105T1 (el) | Ενωσεις πυριδαζινονης και χρηση τους ως αναστολεις του daao | |
| CY1121063T1 (el) | Αναστολεις της συνθασης της αλδοστερονης | |
| DOP2016000276A (es) | 2-AMINO-6-METIL-4,4a,5,6-TETRAHIDROPIRANO[3,4-d][1,3]TIAZIN-8a(8H)-IL-1,3-TIAZOL-4-ILAMIDAS | |
| EA201790088A1 (ru) | Ингибиторы syk | |
| AR089781A1 (es) | Fluorometil-5,6-dihidro-4h-[1,3]oxazinas | |
| UY35551A (es) | Derivados heteroarilos como inhibidores de aldosterona sintasa | |
| DOP2017000034A (es) | Compuestos de imidazopiridazina | |
| EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
| IN2015MN00045A (enExample) | ||
| TR201813294T4 (tr) | N-aril-2-amino-4-aril-pirimidin makrosi̇kli̇k poli̇eter türevleri̇ ve bunlarin flt3 ve jak i̇nhi̇bi̇törleri̇ olarak kullanimlari. |